Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy
Open Access
- 1 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (3) , e023667
Abstract
BACKGROUND: The obesity paradox states that patients with higher body mass index (BMI) and cardiovascular disease may experience better prognosis. However, this is less clear in patients with coronary heart disease. METHODS AND RESULTS: The prospective STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) trial included 15 828 patients with stable coronary heart disease with 3 to 5 years’ follow‐up on optimal secondary preventive treatment. BMI was measured at baseline (n=15 785). Associations between BMI and cardiovascular outcomes were evaluated by Cox regression analyses with multivariable adjustments. Mean age was 64±9 years and 19% women. Most risk markers (diabetes, hypertension, inflammatory biomarkers, triglycerides) showed a graded association with higher BMI. The frequency of smoking, levels of high‐density lipoprotein, growth differentiation factor 15, and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) were higher at lower BMI. Low BMI (2 ; n=244 [1.5%]) was associated with doubled risk of total death (hazard ratio [HR], 2.27; 95% CI, 1.60–3.22), cardiovascular death (HR, 2.26; 95% CI, 1.46–3.49), and heart failure (HR, 2.51; 95% CI, 1.35–4.68) compared with BMI of 25 to 2 (n=6752 [42.8%]) as reference. Similarly, high BMI of ≥35 kg/m 2 (n=1768 [11.2%]) was associated with increased risk of the same outcomes. A BMI between 20 and 2 was associated with increased risk of cardiovascular death (HR, 1.26; 95% CI, 1.03–1.54) and total death (HR, 1.21; 95% CI, 1.03–1.42). CONCLUSIONS: Patients with stable coronary heart disease showed a graded increase in cardiometabolic and inflammatory risk factors with increasing BMI category >25 kg/m 2 . All‐cause and cardiovascular mortality were lowest at BMI of 25 to 35 kg/m 2 . Underweight with BMI of 2 and very high BMI of ≥35 kg/m 2 were strong risk markers for poor prognosis. REGISTRATION: URL: https://clinicaltrials.gov/ ; Unique identifier NCT00799903.Keywords
This publication has 34 references indexed in Scilit:
- Effect of Morbid Obesity on In-Hospital Mortality and Coronary Revascularization Outcomes After Acute Myocardial Infarction in the United StatesThe American Journal of Cardiology, 2013
- Waist‐to‐height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta‐analysisObesity Reviews, 2011
- Impact of body mass index in the results after primary angioplasty in patients with ST segment elevation acute myocardial infarctionAcute Cardiac Care, 2011
- Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseAmerican Heart Journal, 2010
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesThe Lancet, 2009
- Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarctionClinical Research in Cardiology, 2007
- The obesity paradox in non–ST-segment elevation acute coronary syndromes: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement InitiativeAmerican Heart Journal, 2006
- Impact of body mass index on In-Hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry)11*This study was performed with the permission of the New York State Department of Health, which retains ownership of the registry.The American Journal of Cardiology, 2004
- The Obesity Epidemic: Pathophysiology and Consequences of ObesityObesity Research, 2002
- The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox?JACC, 2002